Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 643

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT04655677
A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodg…
Prizloncabtagene Autoleucel SEP Phase 1 COMPLETED En attente / non publié Shanghai AbelZeta Ltd. China · Peking Union Medical College Hospital, Beijin… 2020-10-30 → 2024-06-30 Ouvrir
NCT05800977
ELEVATION — A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patien…
Prizloncabtagene Autoleucel SEP Phase 1/2 RECRUITING En attente / non publié Shanghai AbelZeta Ltd. China · Beijing Cancer Hospital, Beijing, China | Bei… 2023-02-22 → 2028-06-30 Ouvrir
NCT04693676
A Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hod…
Prizloncabtagene Autoleucel SEP Phase 1 UNKNOWN En attente / non publié Shanghai AbelZeta Ltd. China · The First Affiliated Hospital, College of Med… 2020-08-03 → 2024-04-30 Ouvrir
NCT05149391
A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell …
CD19/CD20-directed Chimeric Antig… SEP Phase 1 COMPLETED En attente / non publié Peking University China · Peking University Cancer Hospital, Beijing, C… 2021-07-20 → 2024-05-30 Ouvrir
NCT04317885
A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Sub…
Prizloncabtagene Autoleucel SEP Phase 1 COMPLETED En attente / non publié Shanghai AbelZeta Ltd. China · Shanghai Tongji Hospital, Tongji University S… 2019-11-05 → 2023-12-30 Ouvrir
NCT06590246
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent H…
Armored and GPC3-targeted autolog… SEP Phase 1/2 RECRUITING En attente / non publié Shanghai AbelZeta Ltd. China · The First Affiliated Hospital, Zhejiang Unive… 2024-09-30 → 2043-04-30 Ouvrir
NCT07444281
An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With…
C-CAR031 SEP Phase 1 RECRUITING En attente / non publié Shanghai AbelZeta Ltd. China · Shanghai Chest hospital, Shanghai, China 2024-12-25 → 2028-01-30 Ouvrir
NCT05155189
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection…
C-CAR031 SEP Phase 1 RECRUITING En attente / non publié Shanghai AbelZeta Ltd. China · The First Affiliated Hospital of Zhengzhou Un… 2022-02-21 → 2041-05 Ouvrir
NCT06830577
Intra-ureteric Aminophylline Instillation on Flexible Ureteroscopy Proc…
Usage of Aminophylline prior to u… SEP Non applicable RECRUITING En attente / non publié Ain Shams University Egypt · Ain Shams University Hospitals, Cairo, Egypt 2025-03-01 → 2026-02-01 Ouvrir
NCT01022151
Aminophylline and Cognitive Function After Sevoflurane Anaesthesia
0.2 mL/kg of aminophylline 10 mg/… SEP Phase 2 COMPLETED En attente / non publié King Faisal University Saudi Arabia · King Faisal University, Khobar, Saudi … 2007-11 → 2010-08 Ouvrir
NCT06728943
Efficacy of Intra-Ureteric Aminophylline Installation After Failed Ston…
ureteral dilatation SEP Non applicable RECRUITING En attente / non publié Al-Azhar University Egypt · Al-Azhar university, faculty of medicine, the… 2024-12-01 → 2028-12-01 Ouvrir
NCT02270827
SARAH — A Pilot Study Into Health Pre and Post Treatment With Intraveno…
Aminophylline SEP À vérifier TERMINATED En attente / non publié Shanghai Jiao Tong University Aff… United Kingdom · Royal Brompton Hospital, London, Uni… 2014-06 → 2015-02 Ouvrir
NCT01280071
Adenosine Activity in Producing Venoarteriolar Reflexes
Aminophylline SEP Non applicable UNKNOWN En attente / non publié Shanghai Jiao Tong University Aff… Non communiqué Non communiqué Ouvrir
NCT06498687
Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia
CYR-064 SEP Phase 1 WITHDRAWN En attente / non publié University of Nebraska Non communiqué 2025-04 → 2026-07 Ouvrir
NCT00893009
The Effect on Small Airways of Addition of Theophylline as Inducer of H…
Theophylline SEP Non applicable UNKNOWN En attente / non publié Hospital Universitari Son Dureta Israel · Pulmonar Institute, Assaf Harofeh Medical Ce… 2009-07 → 2009-12 Ouvrir
NCT01125748
XPORT — A Study Evaluating the Persistency of Response With or Without …
Omalizumab SEP Phase 4 COMPLETED En attente / non publié Genentech, Inc. United States · Albany — centre non communiqué, Alban… 2010-05 → 2013-08 Ouvrir
NCT00671151
Effects of Low-Dose Theophylline During Chronic Obstructive Pulmonary D…
Theophylline SEP Non applicable COMPLETED En attente / non publié Hospital Universitari Son Dureta Spain · Hospital Universitario Son Dureta, Palma de M… 2005-06 → 2007-12 Ouvrir
NCT05350150
VNS-EPS — Non-invasive Vagus Nerve Stimulation in Patients Undergoing E…
Auricular Vagal Nerve Stimulation SEP Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Northwell Health United States · Kristie Coleman, New York, United Sta… 2022-08-22 → 2026-07-30 Ouvrir
NCT01479075
Centrin — The Effect of Central Insulin on Insulin Sensitivity and Ener…
intransal insulin SEP Phase 4 COMPLETED En attente / non publié German Diabetes Center Germany · German Diabetic Center, Düsseldorf, Germany 2011-08 → 2014-06 Ouvrir
NCT07577102
taVNS-FMS — Unilateral and Bilateral taVNS in Fibromyalgia
taVNS SEP Non applicable COMPLETED En attente / non publié Spaulding Rehabilitation Hospital Turkey (Türkiye) · Darülaceze Medical Center, Istanbu… 2022-01-01 → 2023-06-20 Ouvrir
NCT01846741
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients E…
M106 VNS Therapy System SEP Non applicable COMPLETED En attente / non publié Cyberonics, Inc. United States · Albany — centre non communiqué, Alban… 2013-07 → 2015-08 Ouvrir
NCT07782866
MindVybe tVNS/APS for Wellbeing in Breast Cancer Survivors
Transcutaneous vagus nerve and ac… SEP Non applicable COMPLETED En attente / non publié The Healing Consciousness Foundat… United States · Redeemer Health, Meadowbrook, United … 2025-04-14 → 2026-07-24 Ouvrir
NCT07730762
A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for…
transcutaneous auricular vagus ne… SEP Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Xijing Hospital China · Xijing Hospital, Shanxi, China 2024-08-30 → 2026-12-31 Ouvrir
NCT06935474
C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease
C-CAR168 SEP Phase 1/2 WITHDRAWN En attente / non publié The Affiliated Hospital of Qingda… United States · AbelZeta, Inc., Rockville, United Sta… 2026-07 → 2030-06 Ouvrir
NCT07729826
C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refrac…
C-CAR168 SEP Phase 2 NOT_YET_RECRUITING En attente / non publié The Affiliated Hospital of Qingda… Non communiqué 2026-09-30 → 2029-09-01 Ouvrir